겸상 적혈구 빈혈 검사 및 스크리닝 시장 규모, 점유율, 동향 분석 보고서 : 기술별, 연령대별, 분야별, 지역별, 부문별 예측(2025-2030년)

Sickle Cell Anemia Testing And Screening Market Size, Share & Trends Analysis Report By Technology (Hemoglobin Electrophoresis, Point-of-Care Tests), By Age Group, By Sector Type, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,590,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,034,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,922,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

겸상 적혈구 빈혈 검사 및 스크리닝 시장 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 겸상 적혈구 빈혈 검사 및 스크리닝 시장 규모는 2025-2030년 동안 연평균 12.1%의 CAGR로 확대되어 2030년에는 8억 2,950만 달러에 달할 것으로 예상됩니다. 헤모글로빈 S(HbS)는 겸상 적혈구 질환의 원인 인자이며 현재 전 세계, 특히 신흥 경제 국가에서 가장 널리 퍼진 질병 또는 유전자 이상입니다.

겸상 적혈구 헤모글로빈 변이체에는 HbS, HbA 및 HbC가 있습니다. 위의 세 가지 헤모글로빈 변이체를 모두 명확하게 구별하기 위해 다양한 검사가 개발되었습니다. 스마트폰의 현미경을 통해 환자의 혈액 도말 샘플에서 겸상 적혈구 빈혈의 자동 스크리닝을 수행하도록 설계된 딥러닝 프레임워크의 개발은 가까운 장래에 시장에 새로운 길을 열어줄 것으로 보입니다.

시장은 적당히 통합되어 있으며, 주요 시장 진입 기업들은 제휴와 인수를 통해 시장 경쟁을 유지하고 신생아 검사 시장 전체에서 사업을 확장하기 위해 노력하고 있습니다. 한편, 신생 기업들은 시장에서 경쟁 우위를 점하기 위해 현장 진료 검사의 가능성을 모색하고 있습니다.

정부 주도의 신생아 선별검사 프로그램 및 평가 연구에서 Hb 전기영동 및 HPLC의 사용이 급증하고 있으며, 그 결과 시장 침투가 가속화되고 있습니다. 그 결과, 기존 제품 라인을 개선하고자 하는 기업들의 관심을 끌면서 제품 소비가 더욱 확대되고 있습니다.

겸상 적혈구 빈혈 검사 및 스크리닝 시장 보고서 하이라이트

• 연령대별로 이 질환의 부담을 효과적으로 관리하기 위해 전 세계적으로 여러 신생아 선별검사 프로그램이 채택되고 있습니다. 이러한 프로그램에는 등전점 집중/셀룰로오스 아세테이트 전기영동, 고성능 액체 크로마토그래피(HPLC), 용해도 검사 등 다양한 검사가 사용되고 있습니다.
• 기술별로는 POC 측면 흐름 분석이 스크리닝 프로그램에서 가장 선호되는 검사 방법이며, 전통적인 검사 수단을 형성하고 있습니다.
• 부문별로는 정부 검사실이 수년 동안 겸상 적혈구 검사를 가장 많이 채택해 왔습니다.
• 정부 검사 기관은 집단 기반 겸상 적혈구 검사를 장려함으로써 이러한 검사의 채택을 촉진하는 데 적극적으로 참여하고 있습니다.
• 헤모글로빈 이상증 및 낭포성섬유증과 같은 질병의 의료 격차 치료 및 진단에 대한 연방 정부 및 재단의 자금 지원에 대한 수요가 증가함에 따라 규제 기관의 관심이 높아질 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 겸상 적혈구 빈혈 검사 및 스크리닝 시장 변수, 동향, 범위

• 시장 계통 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 비즈니스 환경 분석
  • 산업 분석 - Porter's Five Forces 분석
  • PESTLE 분석

제4장 겸상 적혈구 빈혈 검사 및 스크리닝 시장 : 기술별, 비즈니스 분석

• 기술별 시장 점유율, 2024년과 2030년
• 기술별 부문 대시보드
• 시장 규모와 예측과 동향 분석, 기술별, 2018-2030년
• 헤모글로빈 전기영동
• 고속 액체 크로마토그래피(HPLC)
• POC(Point of Care) 검사
• 기타

제5장 겸상 적혈구 빈혈 검사 및 스크리닝 시장 : 연령층별, 비즈니스 분석

• 연령층별 시장 점유율, 2024년과 2030년
• 연령층별 부문 대시보드
• 시장 규모와 예측과 동향 분석, 부문 유형별, 2018-2030년
• 신생아 스크리닝(12개월 이하)
• 성인 스크리닝(25-60세)
• 기타(1-25세와 60세 이상)

제6장 겸상 적혈구 빈혈 검사 및 스크리닝 시장 : 부문 유형별, 비즈니스 분석

• 부문 유형별 시장 점유율, 2024년과 2030년
• 부문 유형별 부문 대시보드
• 시장 규모와 예측과 동향 분석, 부문 유형별, 2018-2030년
• 정부 실험실
• 민간 실험실
• 기업 실험실
• PPP(민관 파트너십)

제7장 겸상 적혈구 빈혈 검사 및 스크리닝 시장 : 기술별, 지역별, 추정·동향 분석

• 지역별 시장 점유율 분석, 2024년과 2030년
• 지역별 시장 대시보드
• 시장 규모, 예측 동향 분석, 2018-2030년
• 북미
  • 국가별, 2018-2030년
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 국가별, 2018-2030년
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 덴마크
  • 스웨덴
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 국가별, 2018-2030년
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 국가별, 2018-2030년
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제8장 겸상 적혈구 빈혈 검사 및 스크리닝 시장 : 연령층별, 지역별, 추정·동향 분석

• 지역별 시장 점유율 분석, 2024년과 2030년
• 지역별 시장 대시보드
• 시장 규모, 예측 동향 분석, 2018-2030년
• 북미
  • 국가별, 2018-2030년
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 국가별, 2018-2030년
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 덴마크
  • 스웨덴
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 국가별, 2018-2030년
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 국가별, 2018-2030년
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제9장 겸상 적혈구 빈혈 검사 및 스크리닝 시장 : 부문 유형별, 지역별, 추정·동향 분석

• 지역별 시장 점유율 분석, 2024년과 2030년
• 지역별 시장 대시보드
• 시장 규모, 예측 동향 분석, 2018-2030년
• 북미
  • 국가별, 2018-2030년
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 국가별, 2018-2030년
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 덴마크
  • 스웨덴
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국

ksm

영문 목차

영문목차

Sickle Cell Anemia Testing And Screening Market Growth & Trends:

The global sickle cell anemia testing and screening market size is expected to reach USD 829.5 million by 2030, expanding at a CAGR of 12.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Hemoglobin S (HbS) is the causative factor for sickle cell disease and is currently the most prevailing disease or genetic abnormality across the globe, specifically across developing economies.

Sickle cell hemoglobin variants are inclusive of HbS, HbA, and HbC. Different tests have been developed to perform a clear distinction between all the three above-mentioned hemoglobin variants. Development of a deep learning framework designed to perform automated screening of sickle cell anemia in blood smear sample of patients via a smartphone microscope is set to open up new avenues for the market in the near future.

The market is moderately consolidated, wherein the key industry participants are striving to sustain market competition via partnerships, acquisitions, and expanding their business across newborn testing market space. Whereas, emerging companies are exploring potential of point-of-care tests to gain a competitive edge in the market.

A steep increase in the uptake of Hb electrophoresis and HPLC across government-initiated newborn screening programs and assessment studies have resulted in robust market penetration. This has, in turn, caught the attention of companies who are keen on modifying their existing product line, further amplifying consumption of the same.

Sickle Cell Anemia Testing And Screening Market Report Highlights:

• By age group, several newborn screening programs have been employed across the globe to effectively manage the burden of this disease. These programs make use of different tests such as isoelectric focusing/ cellulose acetate electrophoresis, high-performance liquid chromatography (HPLC), and solubility tests
• Based on technology, POC lateral flow assays are the most preferred testing methodologies in screening programs, forming the conventional means of testing
• On the basis of sector type, government laboratories have witnessed maximum employment of sickle cell tests over the years
• Government laboratories have actively participated in promoting the adoption of these tests by encouraging population-based sickle cell testing
• Rise in the demand for federal and foundation funding to address healthcare disparities treatments and diagnosis of diseases, such as hemoglobinopathies and cystic fibrosis, is expected to drive the attention of the regulatory agencies.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Technology
  • 1.2.2. Age Group
  • 1.2.3. Sector Type
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Sickle Cell Anemia Testing & Screening Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Sickle Cell Anemia Testing & Screening Market: Technology Business Analysis

• 4.1. Technology Market Share, 2024 & 2030
• 4.2. Technology Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
• 4.4. Hemoglobin Electrophoresis
  • 4.4.1. Hemoglobin Electrophoresis Market, 2018 - 2030 (USD Million)
  • 4.4.2. Isoelectric Focusing
    • 4.4.2.1. Isoelectric Focusing Market, 2018 - 2030 (USD Million)
  • 4.4.3. Others
    • 4.4.3.1. Others Market, 2018 - 2030 (USD Million)
• 4.5. High-Performance Liquid Chromatography (HPLC)
  • 4.5.1. High-Performance Liquid Chromatography (HPLC) Market, 2018 - 2030 (USD Million)
• 4.6. Point-of-Care Tests
  • 4.6.1. Point-of-Care Tests Market, 2018 - 2030 (USD Million)
  • 4.6.2. Lateral Flow Immunoassay
    • 4.6.2.1. Lateral Flow Immunoassay Market, 2018 - 2030 (USD Million)
  • 4.6.3. Paper-Based Rapid Diagnostics
    • 4.6.3.1. Paper-Based Rapid Diagnostics Market, 2018 - 2030 (USD Million)
  • 4.6.4. Others
    • 4.6.4.1. Others Market, 2018 - 2030 (USD Million)
• 4.7. Other Tests
  • 4.7.1. Other Tests Market, 2018 - 2030 (USD Million)

Chapter 5. Sickle Cell Anemia Testing & Screening Market: Age Group Business Analysis

• 5.1. Age Group Market Share, 2024 & 2030
• 5.2. Age Group Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Age Group, 2018 to 2030 (USD Million)
• 5.4. Newborn Screening (12 months and below)
  • 5.4.1. Newborn Screening (12 months and below) Market, 2018 - 2030 (USD Million)
• 5.5. Adult Screening (25 to 60 years)
  • 5.5.1. Adult Screening (25 to 60 years) Market, 2018 - 2030 (USD Million)
• 5.6. Other Age Groups (1 to 25 & above 60 years)
  • 5.6.1. Other Age Groups (1 to 25 & above 60 years) Market, 2018 - 2030 (USD Million)

Chapter 6. Sickle Cell Anemia Testing & Screening Market: Sector Type Business Analysis

• 6.1. Sector Type Market Share, 2024 & 2030
• 6.2. Sector Type Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by Sector Type, 2018 to 2030 (USD Million)
• 6.4. Government Labs
  • 6.4.1. Government Labs Market, 2018 - 2030 (USD Million)
• 6.5. Private Labs
  • 6.5.1. Private Labs Market, 2018 - 2030 (USD Million)
• 6.6. Corporate Labs
  • 6.6.1. Corporate Labs Market, 2018 - 2030 (USD Million)
• 6.7. PPP (Public-Private-Partnerships)
  • 6.7.1. PPP (Public-Private-Partnerships) Market, 2018 - 2030 (USD Million)

Chapter 7. Sickle Cell Anemia Testing & Screening Market: Regional Estimates & Trend Analysis by Technology

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. North America Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Regulatory Framework
    • 7.4.2.3. Competitive Insights
    • 7.4.2.4. U.S. Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Regulatory Framework
    • 7.4.3.3. Competitive Insights
    • 7.4.3.4. Canada Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Regulatory Framework
    • 7.4.4.3. Competitive Insights
    • 7.4.4.4. Mexico Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework
    • 7.5.2.3. Competitive Insights
    • 7.5.2.4. UK Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework
    • 7.5.3.3. Competitive Insights
    • 7.5.3.4. Germany Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework
    • 7.5.4.3. Competitive Insights
    • 7.5.4.4. France Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Regulatory Framework
    • 7.5.5.3. Competitive Insights
    • 7.5.5.4. Italy Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Regulatory Framework
    • 7.5.6.3. Competitive Insights
    • 7.5.6.4. Spain Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Norway
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Regulatory Framework
    • 7.5.7.3. Competitive Insights
    • 7.5.7.4. Norway Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Regulatory Framework
    • 7.5.8.3. Competitive Insights
    • 7.5.8.4. Denmark Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Sweden
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Regulatory Framework
    • 7.5.9.3. Competitive Insights
    • 7.5.9.4. Sweden Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework
    • 7.6.2.3. Competitive Insights
    • 7.6.2.4. Japan Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework
    • 7.6.3.3. Competitive Insights
    • 7.6.3.4. China Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework
    • 7.6.4.3. Competitive Insights
    • 7.6.4.4. India Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework
    • 7.6.5.3. Competitive Insights
    • 7.6.5.4. South Korea Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework
    • 7.6.6.3. Competitive Insights
    • 7.6.6.4. Australia Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Framework
    • 7.6.7.3. Competitive Insights
    • 7.6.7.4. Thailand Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework
    • 7.7.2.3. Competitive Insights
    • 7.7.2.4. Brazil Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Framework
    • 7.7.3.3. Competitive Insights
    • 7.7.3.4. Argentina Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework
    • 7.8.2.3. Competitive Insights
    • 7.8.2.4. South Africa Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Regulatory Framework
    • 7.8.3.3. Competitive Insights
    • 7.8.3.4. Saudi Arabia Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Regulatory Framework
    • 7.8.4.3. Competitive Insights
    • 7.8.4.4. UAE Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Regulatory Framework
    • 7.8.5.3. Competitive Insights
    • 7.8.5.4. Kuwait Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Sickle Cell Anemia Testing & Screening Market: Regional Estimates & Trend Analysis by Age Group

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.4. North America
  • 8.4.1. North America Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Regulatory Framework
    • 8.4.2.3. Competitive Insights
    • 8.4.2.4. U.S. Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Regulatory Framework
    • 8.4.3.3. Competitive Insights
    • 8.4.3.4. Canada Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Regulatory Framework
    • 8.4.4.3. Competitive Insights
    • 8.4.4.4. Mexico Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Regulatory Framework
    • 8.5.2.3. Competitive Insights
    • 8.5.2.4. UK Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Regulatory Framework
    • 8.5.3.3. Competitive Insights
    • 8.5.3.4. Germany Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Regulatory Framework
    • 8.5.4.3. Competitive Insights
    • 8.5.4.4. France Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Regulatory Framework
    • 8.5.5.3. Competitive Insights
    • 8.5.5.4. Italy Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Regulatory Framework
    • 8.5.6.3. Competitive Insights
    • 8.5.6.4. Spain Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Norway
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Regulatory Framework
    • 8.5.7.3. Competitive Insights
    • 8.5.7.4. Norway Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Denmark
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Regulatory Framework
    • 8.5.8.3. Competitive Insights
    • 8.5.8.4. Denmark Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. Sweden
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Regulatory Framework
    • 8.5.9.3. Competitive Insights
    • 8.5.9.4. Sweden Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Regulatory Framework
    • 8.6.2.3. Competitive Insights
    • 8.6.2.4. Japan Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Regulatory Framework
    • 8.6.3.3. Competitive Insights
    • 8.6.3.4. China Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Regulatory Framework
    • 8.6.4.3. Competitive Insights
    • 8.6.4.4. India Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. South Korea
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Regulatory Framework
    • 8.6.5.3. Competitive Insights
    • 8.6.5.4. South Korea Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. Australia
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Regulatory Framework
    • 8.6.6.3. Competitive Insights
    • 8.6.6.4. Australia Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Regulatory Framework
    • 8.6.7.3. Competitive Insights
    • 8.6.7.4. Thailand Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Regulatory Framework
    • 8.7.2.3. Competitive Insights
    • 8.7.2.4. Brazil Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Regulatory Framework
    • 8.7.3.3. Competitive Insights
    • 8.7.3.4. Argentina Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.8. MEA
  • 8.8.1. MEA Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Regulatory Framework
    • 8.8.2.3. Competitive Insights
    • 8.8.2.4. South Africa Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Regulatory Framework
    • 8.8.3.3. Competitive Insights
    • 8.8.3.4. Saudi Arabia Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Regulatory Framework
    • 8.8.4.3. Competitive Insights
    • 8.8.4.4. UAE Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Regulatory Framework
    • 8.8.5.3. Competitive Insights
    • 8.8.5.4. Kuwait Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Sickle Cell Anemia Testing & Screening Market: Regional Estimates & Trend Analysis by Sector Type

• 9.1. Regional Market Share Analysis, 2024 & 2030
• 9.2. Regional Market Dashboard
• 9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 9.4. North America
  • 9.4.1. North America Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 9.4.2. U.S.
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Regulatory Framework
    • 9.4.2.3. Competitive Insights
    • 9.4.2.4. U.S. Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.3. Canada
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Regulatory Framework
    • 9.4.3.3. Competitive Insights
    • 9.4.3.4. Canada Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.4. Mexico
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Regulatory Framework
    • 9.4.4.3. Competitive Insights
    • 9.4.4.4. Mexico Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.5. Europe
  • 9.5.1. Europe Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 9.5.2. UK
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Regulatory Framework
    • 9.5.2.3. Competitive Insights
    • 9.5.2.4. UK Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.3. Germany
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Regulatory Framework
    • 9.5.3.3. Competitive Insights
    • 9.5.3.4. Germany Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.4. France
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Regulatory Framework
    • 9.5.4.3. Competitive Insights
    • 9.5.4.4. France Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.5. Italy
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Regulatory Framework
    • 9.5.5.3. Competitive Insights
    • 9.5.5.4. Italy Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.6. Spain
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Regulatory Framework
    • 9.5.6.3. Competitive Insights
    • 9.5.6.4. Spain Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.7. Norway
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Regulatory Framework
    • 9.5.7.3. Competitive Insights
    • 9.5.7.4. Norway Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.8. Denmark
    • 9.5.8.1. Key Country Dynamics
    • 9.5.8.2. Regulatory Framework
    • 9.5.8.3. Competitive Insights
    • 9.5.8.4. Denmark Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.9. Sweden
    • 9.5.9.1. Key Country Dynamics
    • 9.5.9.2. Regulatory Framework
    • 9.5.9.3. Competitive Insights
    • 9.5.9.4. Sweden Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• 9.6. Asia Pacific
  • 9.6.1. Asia Pacific Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.2. Japan
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Regulatory Framework
    • 9.6.2.3. Competitive Insights
    • 9.6.2.4. Japan Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.3. China
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Regulatory Framework
    • 9.6.3.3. Competitive Insights
    • 9.6.3.4. China Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.4. India
    • 9.6.4.1. Key Country Dynamics
    • 9.6.4.2. Regulatory Framework
    • 9.6.4.3. Competitive Insights
    • 9.6.4.4. India Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.5. South Korea
    • 9.6.5.1. Key Country Dynamics
    • 9.6.5.2. Regulatory Framework
    • 9.6.5.3. Competitive Insights
    • 9.6.5.4. South Korea Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.6. Australia
    • 9.6.6.1. Key Country Dynamics
    • 9.6.6.2. Regulatory Framework
    • 9.6.6.3. Competitive Insights
    • 9.6.6.4. Australia Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.7. Thailand
    • 9.6.7.1. Key Country Dynamics
    • 9.6.7.2. Regulatory Framework
    • 9.6.7.3. Competitive Insights
    • 9.6.7.4. Thailand Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)

관련자료